Sarah Cannon Research Institute: Breast Neoplasms trials

The registry lists 11 Breast Neoplasms studies with Sarah Cannon Research Institute as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 9Phase 3 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerCompletedNCT02187991Phase 2Results posted
• STAR Cape+BKM120 MBC With Brain MetCompletedNCT02000882Phase 2Results posted
• Ixabepilone + Carboplatin Metastatic Breast CancerCompletedNCT01075100Phase 2Results posted
• TAC Versus TC for Adjuvant Breast CancerCompletedNCT00493870Phase 3Results posted
• Adj TC + Herceptin Early Stage Breast CancerCompletedNCT00493649Phase 2Results posted
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast CancerCompletedNCT00303108Phase 2Results posted
• PhII ICb With/Without Erbitux in MBC PtsActive, not recruitingNCT00248287Phase 2Results posted
• Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast CancerActive, not recruitingNCT03379428Phase 1/2
• Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast CancerTerminatedNCT02229149Phase 2
• Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by EverolimusCompletedNCT02229136Phase 2
• Triple Negative Breast Cancer Biomarker StudyCompletedNCT01111175